The analysis was a post hoc observational follow-up of participants from the original randomized COURAGE trial, rather than a new randomized trial. It included veterans whose health records could be linked to the study, a population with...
The analysis was a post hoc observational follow-up of participants from the original randomized COURAGE trial, rather than a new randomized trial. It included veterans whose health records could be linked to the study, a population with...
Using CCTA with the dual-source Naeotom Alpha photon-counting CT scanner from Siemens Healthineers can reduce diagnostic angiography referrals by more than 50% as well as lower costs and shorten hospital stays², due to CCTA’s value in...
Using CCTA with the dual-source Naeotom Alpha photon-counting CT scanner from Siemens Healthineers can reduce diagnostic angiography referrals by more than 50% as well as lower costs and shorten hospital stays², due to CCTA’s value in...
The prospective, single-arm, pre-market study will enroll up to 300 patients in Europe and Australia with symptomatic severe aortic stenosis caused by severe calcium buildup in the aortic valve. The study will be the basis to seek approval...
The prospective, single-arm, pre-market study will enroll up to 300 patients in Europe and Australia with symptomatic severe aortic stenosis caused by severe calcium buildup in the aortic valve. The study will be the basis to seek approval...
Evidence shows that reducing low-density lipoprotein cholesterol (LDL-C), or “bad cholesterol,” significantly lowers the risk of myocardial infarction, stroke and cardiovascular death; however, many high-risk ASCVD patients remain above LDL-C...
Evidence shows that reducing low-density lipoprotein cholesterol (LDL-C), or “bad cholesterol,” significantly lowers the risk of myocardial infarction, stroke and cardiovascular death; however, many high-risk ASCVD patients remain above LDL-C...
GALWAY – Medtronic announced its intent to acquire Contego Medical, a privately held medical device company focused on innovative solutions for carotid artery disease and peripheral thrombectomy.
The acquisition will build on the company’s...
GALWAY – Medtronic announced its intent to acquire Contego Medical, a privately held medical device company focused on innovative solutions for carotid artery disease and peripheral thrombectomy.
The acquisition will build on the company’s...
In the PERISCOPE project, machine-learning models were developed that could accurately predict in-hospital mortality and six-month mortality across three diverse databases.
In the PERISCOPE project, machine-learning models were developed that could accurately predict in-hospital mortality and six-month mortality across three diverse databases.
Zhenyu Li and team’s research suggests physicians may need to closely monitor patients with elevated BNP and consider whether antiplatelet therapy could help prevent or reduce the risk of blood clots and related complications.
Zhenyu Li and team’s research suggests physicians may need to closely monitor patients with elevated BNP and consider whether antiplatelet therapy could help prevent or reduce the risk of blood clots and related complications.
The Neuroguard IEP 3-in-1 system was previously studied for transfemoral and transradial carotid stenting in the PERFORMANCE I and PERFORMANCE II studies. It received FDA PMA approval in October 2024 and is commercially distributed by...
The Neuroguard IEP 3-in-1 system was previously studied for transfemoral and transradial carotid stenting in the PERFORMANCE I and PERFORMANCE II studies. It received FDA PMA approval in October 2024 and is commercially distributed by...
Cambridge, MA – Blackstone Life Sciences (BXLS) announced a $455 million collaboration with Boston Scientific Corporation to co-fund the development of the VITALYST™ Temporary Percutaneous Transvalvular Circulatory Support System program. The...
Cambridge, MA – Blackstone Life Sciences (BXLS) announced a $455 million collaboration with Boston Scientific Corporation to co-fund the development of the VITALYST™ Temporary Percutaneous Transvalvular Circulatory Support System program. The...